Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cg Oncology Inc (CGON)

Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,180,010
  • Shares Outstanding, K 76,038
  • Annual Sales, $ 200 K
  • Annual Income, $ -48,610 K
  • EBIT $ -96 M
  • EBITDA $ -99 M
  • 60-Month Beta N/A
  • Price/Sales 10,444.04
  • Price/Cash Flow N/A
  • Price/Book 3.50

Options Overview Details

View History
  • Implied Volatility 73.05% ( -5.39%)
  • Historical Volatility 55.64%
  • IV Percentile 9%
  • IV Rank 46.73%
  • IV High 154.72% on 05/02/24
  • IV Low 1.40% on 03/13/24
  • Put/Call Vol Ratio 26.00
  • Today's Volume 27
  • Volume Avg (30-Day) 222
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 4,454
  • Open Int (30-Day) 2,669

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.38
  • Number of Estimates 3
  • High Estimate -0.30
  • Low Estimate -0.47
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.00 +6.19%
on 12/19/24
36.73 -21.94%
on 12/04/24
-3.57 (-11.07%)
since 11/20/24
3-Month
27.00 +6.19%
on 12/19/24
40.47 -29.16%
on 11/11/24
-10.33 (-26.49%)
since 09/20/24

Most Recent Stories

More News
CG Oncology Closes $238 Million Public Offering of Common Stock

CG Oncology closed a public offering of 9.2 million shares, raising $238 million for bladder cancer therapy development.Quiver AI SummaryCG Oncology, Inc., a clinical biopharmaceutical company specializing...

CGON : 28.67 (+2.32%)
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

CGON : 28.67 (+2.32%)
CG Oncology Announces Pricing of Public Offering for 8 Million Shares of Common Stock at $28 Per Share

CG Oncology announces public offering of 8,000,000 shares at $28 each, expected to raise $204.4 million.Quiver AI SummaryCG Oncology, Inc. has announced the pricing of its public offering of 8 million...

CGON : 28.67 (+2.32%)
CG Oncology Announces Pricing of Public Offering

CGON : 28.67 (+2.32%)
CG Oncology Files Registration Statement for Proposed Public Offering of Common Stock

CG Oncology files for a public offering of 7.3 million shares, with additional shares from existing stockholders.Quiver AI SummaryCG Oncology, Inc., a clinical biopharmaceutical company focused on bladder...

CGON : 28.67 (+2.32%)
CG Oncology Announces Proposed Public Offering

CGON : 28.67 (+2.32%)
Insider Sale: Director at $CGON (CGON) Sells 750 Shares

LEONARD E POST, a director at $CGON ($CGON), sold 750 shares of the company on 12-06-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 75.0% of their shares....

CGON : 28.67 (+2.32%)
CG Oncology and SUO-CTC Launch First Annual NMIBC Research Fellowship to Advance Bladder Cancer Research

SUO-CTC and CG Oncology announce a fellowship to advance research in Non-Muscle Invasive Bladder Cancer. Applications due February 2025.Quiver AI SummaryThe Society of Urologic Oncology Clinical Trials...

CGON : 28.67 (+2.32%)
SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

CGON : 28.67 (+2.32%)
CG Oncology Reports Promising Phase 3 BOND-003 Data for Cretostimogene in High-Risk Bladder Cancer

CG Oncology reports 74.5% complete response in Phase 3 trial for high-risk bladder cancer; favorable safety profile noted.Quiver AI SummaryCG Oncology, Inc. has announced encouraging topline results from...

CGON : 28.67 (+2.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology is based in IRVINE, Calif.

See More

Key Turning Points

3rd Resistance Point 30.57
2nd Resistance Point 29.76
1st Resistance Point 29.21
Last Price 28.67
1st Support Level 27.85
2nd Support Level 27.04
3rd Support Level 26.49

See More

52-Week High 50.23
Fibonacci 61.8% 40.89
Fibonacci 50% 38.00
Fibonacci 38.2% 35.11
Last Price 28.67
52-Week Low 25.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar